Steven J. Frank, MD, is an endowed tenured professor of Radiation Oncology at the University of Texas MD Anderson Cancer Center. He holds the Bessie McGoldrick Professorship in Clinical Research, and is a fellow of the ABS, ACR, and ASTRO. Dr. Frank is the Executive Director of Technology and Innovation and Deputy Head of Strategy. He is amongst the first, if not the first, to use IMPT to treat head and neck tumors. He is the Principal Investigator of a US Phase III randomized trial of IMRT versus IMPT in advanced stage oropharyngeal cancer. Dr. Frank has over 350 peer-reviewed publications and recently published the first textbook on Proton Therapy. Dr. Frank’s lab is studying the biologic enhancement factor of proton therapy and FLASH radiotherapy for in head and neck and prostate models developed in his lab. Dr. Frank has pioneered MRI-Assisted Radiosurgery (MARS) as the next generation of prostate brachytherapy. Dr. Frank has led to the development and FDA approval of multiple novel positive-contrast implantable markers for use in MRI-guided LDR and HDR prostate brachytherapy and external beam radiation therapy. Dr. Frank has served as the past President and Chairman of the Board of the American Brachytherapy Society and was the 2023 recipient of the Ulrich Henschke Award, the highest honor awarded by the ABS on a practitioner of brachytherapy. Dr. Frank is currently serving on the Board of Directors for NAPT and the Board of Trustees for the ABR.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none